ARTV — ARTIVA BIOTHERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 75 SEC-registered investment managers reported holding ARTV (ARTIVA BIOTHERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $420.61M across 43.36M shares. That is +82.6% by share count (+13.41M shares) versus the previous quarter, while reported value moved +175.0%. Ownership is concentrated: the five largest holders account for 64.4% of reported value and the top ten for 82.2%.
Compared with the prior quarter, 42 opened new positions, 24 added to existing stakes, 2 trimmed, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ARTIVA BIOTHERAPEUTICS INC (ARTV) include RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, Fidelity Management & Research (FMR), ranked by reported 13F value among the 146 institutional holders on this page.
ARTV is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding ARTV
The superinvestors we track who report ARTV in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 2.60M | $25.26M | 0.07% | New |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 68 | 18.77M | $227.14M | +136.0% |
| Q2 2026 | 75 | 43.36M | $420.61M | +82.6% |
| Q1 2026 | 42 | 17.15M | $110.47M | -2.5% |
| Q4 2025 | 36 | 17.37M | $74.51M | -3.7% |
| Q3 2025 | 41 | 18.61M | $53.41M | +1.6% |
| Q2 2025 | 49 | 19.03M | $28.73M | -9.5% |
| Q1 2025 | 56 | 22.04M | $66.11M | -0.2% |
| Q4 2024 | 59 | 22.30M | $224.68M | +1.9% |
Over the 8 quarters shown, institutional share counts decreased 16% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+82.6%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.13M | $63.84M | 12.00% | Add | |
| 2.88M | $48.12M | 0.00% | Add | |
| 1.81M | $21.17M | 0.00% | Add | |
| 1.80M | $15.64M | 0.00% | Add | |
| 935.72K | $15.63M | 0.02% | New | |
| 672.78K | $11.24M | 1.78% | New | |
| 2.04M | $8.61M | 0.00% | Add | |
| 752.56K | $7.47M | 0.00% | Add | |
| 396.74K | $5.63M | 0.00% | Add | |
| 696.44K | $4.96M | 2.63% | Hold | |
| 250.00K | $4.17M | 0.19% | New | |
| 268.80K | $3.06M | 0.00% | Add | |
| 363.46K | $2.81M | 0.00% | Add | |
| 300.00K | $2.14M | 0.10% | Hold | |
| 299.31K | $2.13M | 26.60% | Hold | |
| 268.61K | $2.00M | 0.00% | Add | |
| 109.83K | $1.12M | 0.00% | Add | |
| 60.57K | $1.10M | 0.00% | New | |
| 101.36K | $721.65K | 0.01% | Hold | |
| 74.08K | $527.43K | 0.00% | Reduce | |
| 49.70K | $441.12K | 0.00% | Add | |
| 25.39K | $423.95K | 0.24% | New | |
| 24.09K | $402.35K | 0.03% | New | |
| 20.54K | $343.08K | 0.00% | New | |
| 44.81K | $319.08K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.85M | $63.46M | 0.67% | Hold | |
| 2.35M | $15.16M | 4.21% | Hold | |
| 1.61M | $10.37M | 0.39% | Hold | |
| 531.34K | $3.42M | 1.22% | Reduce | |
| 520.33K | $3.35M | 0.00% | Hold | |
| 299.31K | $1.93M | 2.86% | Hold | |
| 213.39K | $1.37M | 0.00% | Hold | |
| 207.69K | $1.34M | 0.00% | New | |
| 194.11K | $1.25M | 0.00% | Hold | |
| 194.11K | $1.25M | 0.00% | Hold | |
| 146.37K | $949.82K | 0.60% | New | |
| 123.27K | $793.86K | 0.00% | Reduce | |
| 123.27K | $793.86K | 0.00% | Reduce | |
| 115.04K | $740.86K | 0.00% | Reduce | |
| 101.69K | $655.45K | 0.00% | Add | |
| 100.00K | $644.00K | 0.00% | Hold | |
| 80.04K | $515.45K | 0.00% | Reduce | |
| 39.50K | $254.35K | 0.00% | Reduce | |
| 35.82K | $230.71K | 0.00% | Hold | |
| 35.00K | $225.40K | 0.01% | Hold | |
| 32.81K | $211.30K | 0.00% | New | |
| 30.70K | $197.72K | 0.00% | New | |
| 25.00K | $161.00K | 0.10% | New | |
| 23.23K | $149.60K | 0.00% | New | |
| 21.58K | $138.98K | 0.00% | New |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.85M | $42.27M | 0.43% | Hold | |
| 2.35M | $10.10M | 3.17% | Hold | |
| 1.61M | $6.91M | 0.34% | Hold | |
| 648.51K | $2.78M | 1.29% | Reduce | |
| 520.33K | $2.23M | 0.00% | Hold | |
| 299.31K | $1.28M | 1.54% | New | |
| 246.01K | $1.06M | 0.00% | Add | |
| 217.10K | $931.35K | 0.00% | Reduce | |
| 217.10K | $931.35K | 0.00% | Reduce | |
| 212.54K | $911.79K | 0.00% | Reduce | |
| 194.11K | $832.72K | 0.00% | Hold | |
| 194.11K | $832.72K | 0.00% | Hold | |
| 144.86K | $621.47K | 0.00% | Add | |
| 116.20K | $498.50K | 0.00% | Add | |
| 101.12K | $434.13K | 0.00% | Reduce | |
| 100.00K | $429.00K | 0.00% | Hold | |
| 79.56K | $341.31K | 0.00% | New | |
| 40.67K | $174.48K | 0.00% | New | |
| 36.87K | $158.19K | 0.00% | Add | |
| 35.82K | $153.69K | 0.00% | Reduce | |
| 35.00K | $150.15K | 0.00% | Hold | |
| 27.76K | $119.08K | 0.07% | New | |
| 27.07K | $116.14K | 0.00% | Reduce | |
| 21.10K | $90.52K | 0.00% | New | |
| 12.06K | $51.74K | 0.00% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.85M | $28.28M | 0.35% | Hold | |
| 2.35M | $6.75M | 2.47% | Hold | |
| 1.61M | $4.62M | 0.26% | Hold | |
| 1.15M | $3.30M | 1.87% | Hold | |
| 798.40K | $2.29M | 0.00% | Add | |
| 520.33K | $1.49M | 0.00% | Hold | |
| 294.42K | $844.99K | 0.00% | Reduce | |
| 262.16K | $752.40K | 0.00% | Reduce | |
| 262.16K | $752.40K | 0.00% | Reduce | |
| 194.11K | $557.09K | 0.00% | Hold | |
| 194.11K | $557.09K | 0.00% | Hold | |
| 159.12K | $456.67K | 0.00% | Reduce | |
| 118.55K | $340.23K | 0.00% | Add | |
| 110.90K | $318.51K | 0.00% | Reduce | |
| 105.57K | $303.00K | 0.00% | Add | |
| 100.00K | $287.00K | 0.00% | Hold | |
| 79.15K | $227.15K | 0.00% | New | |
| 59.82K | $171.69K | 0.00% | Reduce | |
| 49.78K | $142.86K | 0.00% | Reduce | |
| 47.97K | $137.68K | 0.01% | New | |
| 42.83K | $122.92K | 0.00% | Reduce | |
| 39.13K | $112.31K | 0.01% | New | |
| 35.00K | $100.45K | 0.00% | Hold | |
| 26.95K | $77.00K | 0.00% | Reduce | |
| 25.55K | $73.33K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.85M | $14.88M | 0.25% | Hold | |
| 2.35M | $3.55M | 1.37% | Hold | |
| 1.61M | $2.43M | 0.18% | Hold | |
| 1.15M | $1.73M | 1.51% | Reduce | |
| 520.33K | $785.69K | 0.00% | Hold | |
| 485.73K | $733.45K | 0.00% | Reduce | |
| 327.07K | $493.87K | 0.00% | New | |
| 327.07K | $493.87K | 0.00% | New | |
| 291.67K | $440.42K | 0.09% | Hold | |
| 283.12K | $427.52K | 0.00% | Hold | |
| 232.97K | $351.79K | 0.00% | Reduce | |
| 194.11K | $293.10K | 0.00% | Hold | |
| 194.11K | $293.10K | 0.00% | Hold | |
| 159.04K | $240.27K | 0.00% | Reduce | |
| 153.74K | $232.15K | 0.00% | Add | |
| 118.00K | $178.19K | 0.00% | Add | |
| 100.00K | $151.00K | 0.00% | Hold | |
| 77.66K | $117.00K | 0.00% | New | |
| 62.87K | $94.94K | 0.00% | Reduce | |
| 52.21K | $78.84K | 0.00% | New | |
| 46.25K | $69.83K | 0.00% | Add | |
| 45.46K | $68.64K | 0.10% | Hold | |
| 44.22K | $66.77K | 0.00% | New | |
| 42.28K | $63.84K | 0.00% | Add | |
| 41.40K | $62.51K | 0.00% | New |
New Positions (Q2 2026)
- Viking Global Investors 2.60M sh · $25.26M
- VIKING GLOBAL INVESTORS LP 2.60M sh · $25.26M
- Blackstone Inc. 2.40M sh · $23.31M
- Caligan Partners LP 1.74M sh · $16.84M
- Samsara BioCapital, LLC 954.86K sh · $9.26M
- Blue Owl Capital Holdings LP 874.54K sh · $8.48M
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K sh · $5.09M
- GEODE CAPITAL MANAGEMENT, LLC 353.85K sh · $3.43M
- BOOTHBAY FUND MANAGEMENT, LLC 314.38K sh · $3.05M
- Nantahala Capital Management, LLC 300.00K sh · $2.91M
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M
- KVP Capital Advisors, LP 200.00K sh · $1.94M
Fully Exited (vs previous quarter)
- venBio Partners LLC sold 531.34K sh · $3.42M
- Millennium Management sold 123.27K sh · $793.86K
- MILLENNIUM MANAGEMENT LLC sold 123.27K sh · $793.86K
- JANE STREET GROUP, LLC sold 39.50K sh · $254.35K
- STATE STREET CORP sold 35.82K sh · $230.71K
- PANAGORA ASSET MANAGEMENT INC sold 30.70K sh · $197.72K
- Sanctuary Advisors, LLC sold 21.58K sh · $138.98K
- OMERS ADMINISTRATION Corp sold 11.40K sh · $73.42K
- OSAIC HOLDINGS, INC. sold 18 sh · $116
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Blue Owl Capital Holdings LP | 4.13M | 874.54K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 2.88M | 3.56K | 3.53K | 3.56K | 4.92K | 42.28K | 3.56K | 900 | 160 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.81M | 981.82K | 207.69K | — | — | — | — | — | — |
| BlackRock Inc | 1.80M | 694.73K | 213.39K | 212.54K | 294.42K | 485.73K | 1.25M | 1.05M | 837.61K |
| Aberdeen Group plc | 935.72K | — | — | — | — | — | — | — | — |
| Sanofi | 672.78K | — | — | — | — | — | — | — | — |
| Franklin Resources | 2.04M | 2.00M | 520.33K | 520.33K | 520.33K | 520.33K | 520.33K | 520.30K | 520.30K |
| Geode Capital Management | 752.56K | 353.85K | 101.69K | 101.12K | 110.90K | 159.04K | 410.46K | 315.76K | 308.93K |
| UBS Group AG | 396.74K | 184.02K | 1.53K | 36.87K | 21.14K | 3.34K | 43.08K | 35.38K | 6.62K |
| Propel Bio Management, LLC | 696.44K | 696.44K | 146.37K | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 250.00K | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 268.80K | 148.39K | 32.81K | — | — | — | — | — | — |
| STATE STREET CORP | 363.46K | — | 35.82K | 35.82K | 59.82K | 62.87K | 171.78K | 164.78K | 86.56K |
| Nantahala Capital Management, LLC | 300.00K | 300.00K | — | — | — | — | — | — | — |
| Revelation Capital Management, LLC | 299.31K | 299.31K | 299.31K | 299.31K | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 268.61K | 31.11K | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 109.83K | 14.86K | — | — | — | 41.40K | — | — | — |
| TD ASSET MANAGEMENT INC | 60.57K | — | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 101.36K | 101.36K | 23.23K | — | — | — | — | — | — |
| Renaissance Technologies | 74.08K | 151.00K | 80.04K | 116.20K | 79.15K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ARTV?
As of 2026-Q2, 75 institutional funds reported holding ARTV (ARTIVA BIOTHERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $420.61M.
How many shares of ARTV do institutions own?
13F filers reported 43.36M shares of ARTV, worth $420.61M in aggregate at the end of 2026-Q2.
Is institutional ownership of ARTV rising or falling?
Share counts moved +82.6% versus the prior quarter — accumulation.
Who are the top institutional holders of ARTV?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, Fidelity Management & Research (FMR), Viking Global Investors, VIKING GLOBAL INVESTORS LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARTIVA BIOTHERAPEUTICS INC?
The major shareholders of ARTIVA BIOTHERAPEUTICS INC (ARTV) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, Fidelity Management & Research (FMR), Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 146 institutional holders.
Which legendary investors own ARTV?
1 of the legendary investors tracked on HoldingsHub report ARTV (ARTIVA BIOTHERAPEUTICS INC) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ARTV?
1 tracked superinvestors hold ARTV simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.